1-1 of 1
Ramakrishnan V Parameswaran, MD
Close
Save search
Sort by
Journal Articles

Dacetuzumab (SGN-40), Lenalidomide, and Weekly Dexamethasone in Relapsed or Refractory Multiple Myeloma: Multiple Responses Observed in a Phase 1b Study.

Free
Edward Agura, MD, Ruben Niesvizky, MD, Jeffrey Matous, MD, Nikhil Munshi, MD, Mohamad Hussein, MD, Ramakrishnan V Parameswaran, MD, Stefano Tarantolo, MD, Nancy C Whiting, PharmD, BCOP, Jonathan G Drachman, MD, Jeffrey A Zonder, MD
Journal: Blood
Blood (2009) 114 (22): 2870.
https://doi.org/10.1182/blood.V114.22.2870.2870
Published: 2009